CMA fines firms over £35m for illegal arrangement for NHS drug
CMA fines firms in relation to an arrangement under which a competitor was paid not to launch a product, and which enabled price increases From 2013 to 2017, the prices paid by the NHS for prochlorperazine rose from £6.49 per pack of 50 tablets to … read more